Download PDF
1 / Pages

Other users also viewed these articles

Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España Rafael Ruiz-Montero; David Epstein; Bernardo Guzmán Herrador; Jaime Espín Balbino;
Gac Sanit. 2020;34:318-25
Evaluation of new medicines in Spain and comparison with other European countries David Epstein; Jaime Espín;
Gac Sanit. 2020;34:133-40
Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing Marta Trapero-Bertran; Jaume Puig-Junoy; Emilio J. Alegre-del-Rey; Ana Clopés; Félix Lobo; Ana Ortega;
10.1016/j.gaceta.2024.102439